Free alerts

MNPR insider buying

Every open-market purchase of Monopar Therapeutics (MNPR) stock by its officers, directors and major shareholders, from SEC Form 4 filings.

Bought, last 12 months$104.92K
Insiders buying (12m)1
Purchases on record1
Last purchase filedDec 29, 2025

In the last 12 months, 1 insider of Monopar Therapeutics bought $104.92K of MNPR stock on the open market in 1 reported purchase. The most recent was filed on Dec 29, 2025: Vu Quan Anh (Chief Financial Officer) bought 1,500 shares at $69.95, worth $104.92K.

Get the next MNPR insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.

Join free on Telegram

All MNPR insider purchases

FiledInsiderValueSharesPriceStakeTrade
Dec 29Vu Quan AnhChief Financial Officer$104.92K1,500$69.95newDec 26SEC